• Tofacitinib Workflows for RA Macrophage Research

  2026-09-04

  Tofacitinib (CP-690550) helps researchers dissect JAK/STAT-dependent inflammation, GM-CSF-driven macrophage activation, and mitochondrial stress in rheumatoid arthritis models. This guide translates the latest RA macrophage findings into practical assay workflows, dosing logic, controls, and troubleshooting strategies.

• Tofacitinib (CP-690550) and RA Macrophage Repair

  2026-09-04

  A translational perspective on how Tofacitinib links JAK/STAT pathway control with inflammatory and mitochondrial-state correction in GM-CSF-reprogrammed rheumatoid arthritis macrophages.

• Sulfo-NHS-LC-Biotin: Practical Labeling Guide

  2026-09-03

  Sulfo-NHS-LC-Biotin is a water-soluble reagent for stable covalent biotinylation of primary amines on proteins, peptides, and intact-cell surface proteins. It is suited to biotin-avidin or streptavidin capture workflows, but not to intracellular labeling or reversible modification.

• XG005 and Somatic Mutations in SARS-CoV-2 Neutralization

  2026-09-03

  The Cell Reports study shows that fortuitous somatic mutations can transform one member of an antibody family into XG005, a potent and broadly neutralizing antibody against SARS-CoV-2 variants, including Omicron sublineages. Structural comparison, antibody engineering, and mouse challenge experiments connect specific sequence changes with neutralization breadth and therapeutic performance.

• PPT for ERα Signaling: Assay Workflows

  2026-09-02

  PPT (Propyl Pyrazole Triol) enables controlled activation of ERα while minimizing confounding ERβ signaling. This guide translates that selectivity into practical workflows for receptor validation, ERα-mediated gene expression, and mechanistic studies of female lung adenocarcinoma.

• Heparin sodium for Coagulation & Uptake Studies

  2026-09-02

  Heparin sodium provides a practical bridge between anticoagulation assays and mechanistic studies of sulfated-glycan-dependent nanovesicle uptake. This guide covers solution handling, anti-factor Xa activity assay design, activated partial thromboplastin time measurement, HSPG-competition experiments, and troubleshooting for reproducible research workflows.

• Potassium Iodide (KI) Research Workflows

  2026-09-01

  Potassium Iodide (KI) is a practical iodide-source and competition reagent for controlled thyroid-cell, uptake, and protection-mechanism studies. This workflow-focused guide also extracts a transferable lesson from responsive immunotherapy research: sequence exposures, define controls, and separate mechanistic analogy from direct evidence.

• Lactate and L-Lactate in Metabolic Research

  2026-09-01

  Lactate and L-lactate connect pyruvate reduction, NAD+ regeneration, monocarboxylate transport, and tissue-level metabolic communication. In colorectal cancer, a 2026 MedComm study linked NAT1 loss to ENO1 activation, increased lactate production, TRAF6 activation, and PD-L1 stabilization in preclinical models.

• Dabigatran Workflows for Thrombin Inhibition Assays

  2026-08-31

  Dabigatran, also known as Pradaxa, gives researchers a reversible way to interrogate thrombin activity across biochemical and plasma-based models. This guide connects assay design, metabolite-aware interpretation, clinical evidence, and troubleshooting for more reproducible anticoagulation studies.

• Talabostat mesylate: Applied Assay Workflows

  2026-08-31

  Talabostat mesylate, also known as PT-100, enables paired biochemical, tumor-cell, and immune readouts for studying DPP4/FAP biology. This workflow-focused guide emphasizes FAP-status controls, soluble-stock handling, and careful separation of DPP4/FAP assays from DPP9 inflammasome experiments.

• Instant Clot-Forming TXA–SNAP–Propolis Dressings

  2026-08-30

  Nguyen and colleagues developed a bilayer dressing that combines tranexamic acid with an NO donor and propolis to address hemorrhage control and bacterial contamination in trauma wounds. Laboratory assays showed rapid fibrin-network formation and substantial reductions in bacterial colony counts, but the findings remain preclinical and require validation in animal and clinical models.

• Ridaforolimus: Designing Smarter Senescence Assays

  2026-08-29

  Ridaforolimus and Deforolimus provide a precise way to perturb mTOR signaling while separating cytostasis from true senolysis. This guide connects mechanistic data with AI-informed assay design, apoptosis testing, angiogenesis inhibition, and cancer-cell research.

• HOXC8, Caspase-1, and Pyroptosis in Lung Cancer

  2026-08-28

  The reference study identifies HOXC8 as a transcriptional suppressor of CASP1 in non-small cell lung carcinoma, revealing a mechanism by which tumor cells avoid caspase-1–dependent pyroptosis. Its genetic, pharmacological, and tumor-model evidence connects HOXC8 to HDAC1/2-mediated chromatin regulation and suggests that restoring caspase-1 activity may have therapeutic relevance.

• Erastin Ferroptosis Workflows for TEAD2 and HCC

  2026-08-28

  Build more informative ferroptosis experiments by pairing Erastin exposure with redox, iron, and TEAD2 measurements in hepatocellular carcinoma models. This workflow combines a practical 10 μM, 24-hour starting condition with genotype- and pathway-aware optimization for cancer biology research.

• Caffeic Acid Phenethyl Ester in NF-κB Assays

  2026-08-27

  Caffeic Acid Phenethyl Ester (CAPE) enables focused interrogation of NF-κB signaling in neuroinflammation, angiogenesis, and tumor-invasion workflows. This guide connects concentration control, pathway-specific readouts, and the Fyn–Stat3–NF-κB findings of a recent zebrafish study to practical bench decisions.

8620 records 1/575 page Next 12345 下5页 Last page